Clinical Study

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma

Figure 2

Mean deviation values before and after changing to latanoprost/timolol maleate fixed-combination eye drops or to dorzolamide/timolol maleate fixed-combination eye drops (Friedmann analysis). There were no significant differences from baseline in mean deviation values in either medication group at any time point examined. Average data are presented and error bars represent one standard deviation.
975429.fig.002